ADVFN - Advanced Financial Network.
HOME» NASDAQ » H » HGSI Stock Price » HGSI Stock News

Human Genome Sciences Share News

 Human Genome Sciences (mm) Stock Price
HGSI Stock Price
 Human Genome Sciences (mm) Stock Chart
HGSI Stock Chart
 Human Genome Sciences (mm) Stock News
HGSI Stock News
 Human Genome Sciences (mm) Company Information
HGSI Company Information
 Human Genome Sciences (mm) Stock Trades
HGSI Stock Trades

US Stock Futures Higher On Optimism Ahead Of EU Summit

By Nick Godt U.S. stock futures pointed to a higher open Wednesday, lifted by hopes that a much-awaited summit of European leaders will present a convincing plan to handle the euro zone's debt crisis. Futures on the Dow Jones Industrial Average rose 57 points to 11,719 and those on the Standard & Poor's 500 stock index advanced 6.4 points to 1,231. Nasdaq 100 futures gained 11 points to 2,332.70. Stocks fell sharply on Tuesday, with the DJIA falling 1.7% and the S&P 500 losing 2%. U.S. data and earnings disappointed investors while markets remained shaky given uncertainty over the European Union's plans. German Chancellor Angela Merkel spoke to parliament in Berlin Wednesday ahead of a vote on boosting the firepower of the 440 billion euro ($612 billion) euro-zone rescue fund known as the European Financial Stability Facility. The German parliament is expected to back Merkel in the vote and give her a mandate to negotiate a package of measures to tackle the debt crisis at a summit of euro-zone leaders in Brussels later Wednesday. At the summit, leaders are expected to announce details on recapitalizing European banks, addressing Greece's debt burden and boosting the EFSF's firepower. "There really isn't an expectation for a 'solution' versus a 'plan'," said Marc Pado, strategist at Cantor Fitzgerald, in a note. "A plan will provide the framework going forward." In U.S. economic news, data on September durable-goods orders are out at 8:30 a.m. EDT. New-home-sales data for September are due at 10 a.m. EDT. Investors have grown hopeful for the housing market in recent days after a number of Federal Reserve officials said the central bank could do more to support it. Highlights in U.S. earnings include results from Boeing Co. (BA), Ford Motor Co. (F) and Sprint Nextel Corp. (S). Amazon.com Inc. (AMZN) shares fell 11% in preopen trading after the online retailer posted results that fell short of market estimates Tuesday after the close. U.S.-listed shares of Nokia Corp. (NOK) climbed 2.1% in preopen trade after the firm unveiled inaugural devices that will run on Microsoft Corp.'s (MSFT) Windows Phone operating system. -By Nick Godt; 415-439-6400; AskNewswires@dowjones.com

Stock News for Human Genome Sciences (HGSI)
DateTimeHeadline
08/03/201203:00:56GlaxoSmithKline Completes Acquisition of Human Genome Sciences
07/30/201209:06:49GlaxoSmithKline Gets 79% Tenders for Human Genome Sciences Offer
07/15/201219:10:13Glaxo Eyes Human Genome Sciences for $2.6 Billion
07/15/201215:49:18Sources Say GlaxoSmithKline in Talks to Acquire Human Genome...
07/11/201212:36:14Glaxo To File Experimental Diabetes Drug Albiglutide In Early...
07/10/201208:38:08Human Genome: FDA Sets Dec. 15 Action Date For Anthrax Treatment...
07/03/201217:08:09GlaxoSmithKline Readies Candidates to Replace Human Genome's...
06/29/201209:24:03Glaxo Keeps Pressure On Human Genome By Extending Offer To July...
06/29/201207:35:49GlaxoSmithKline Sets July 20 For Expiration Of Tender Offer To...
06/15/201210:42:11GSK Gets Renewed Invitation to Human Genome Sciences Strategic...
06/08/201209:10:55GlaxoSmithKline Extends HGS Offer To June 29
06/07/201211:43:24Glaxo Seen Likely to Extend Hostile Tender Offer for Human Genome
05/30/201211:58:59GlaxoSmithKline Is Said To Plan Effort To Replace Human Genome...
05/23/201209:12:46Glaxo Amends Offer To Address HGS Shareholder Rights Plan
05/17/201217:45:35ADR Report: Shares Lower As Euro-Zone Worries Loom
05/17/201213:54:16GlaxoSmithKline Offer To Acquire HGS Represents Full, Fair Value
05/17/201207:55:44Human Genome Adopts Poison Pill With 15% Trigger To Deter Glaxo
05/09/201209:33:24WSJ BLOG/Health: A.M. Vitals: GSK's Hostile Human Genome Bid;...
05/09/201205:02:12Glaxo Goes Direct To HGS Shareholders With Hostile Offer
05/09/201202:48:24GlaxoSmithKline To Launch $13/Share Tender Offer For To Buy HGS

Human Genome Sciences and other NASDAQ stock quotes are delayed by at least 20 minutes.
All other stock price and quote data is delayed by at least 15 minutes unless otherwise stated. By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Contact Us | Copyright 1999-2007 ADVFN PLC. | Privacy Policy | Investment Warning | Data accreditations | Investor Relations

ADVFNADVFN ItalyADVFN GermanyADVFN FranceADVFN BrazilADVFN JapanADVFN UKADVFN US noad